D. F. V. Lewis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
D. F. V. Lewis has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
M. H. Tarbit
Molecular Toxicology Group , School of Biological Sciences, University of Surrey, Guildford GU2 5XH, UK GlaxoWellcome Research and Development , SG12 0DP, UK
2 shared publicationsP. J. Eddershaw
Molecular Toxicology Group , School of Biological Sciences, University of Surrey, Guildford GU2 5XH, UK GlaxoWellcome Research and Development , SG12 0DP, UK
2 shared publicationsP. S. Goldfarb
Molecular Toxicology Group , School of Biological Sciences, University of Surrey, Guildford GU2 5XH, UK GlaxoWellcome Research and Development , SG12 0DP, UK
2 shared publicationsG.G. Gibson
School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK
1 shared publicationM.S. Ogg
CMR International, Novellus Court, 61 South Street, Epsom, Surrey KT18 7PX, UK
1 shared publicationP.S. Goldfarb
School of Biomedical and Life Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK
1 shared publication
Latest Publications
- 1 October 2002
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 82 (2-3) , 195-199
Molecular modelling of the human glucocorticoid receptor (hGR) ligand-binding domain (LBD) by homology with the human estrogen receptor α (hERα) LBD: quantitative structure–activity relationships within a series of CYP3A4 inducers where induction is mediated via hGR involvement
- 1 October 2002
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 82 (2-3) , 195-199
Molecular modelling of the human glucocorticoid receptor (hGR) ligand-binding domain (LBD) by homology with the human estrogen receptor α (hERα) LBD: quantitative structure–activity relationships within a series of CYP3A4 inducers where induction is mediated via hGR involvement
- 1 January 1997
- Published by Taylor & Francis in Xenobiotica
- Vol. 27 (4) , 319-340
Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102 : structural studies on specific CYP2D6substrate metabolism
1. A molecular model of CYP2D6 has been constructed from the bacterial form CYP102 via a homology alignment between the CYP2D subfamily and CYP102 protein sequences. 2. A number of typical CYP2D6 substrates are shown to fit the putative active site of the enzyme, as can the specific inhibitor quinidine. 3. Some of the allelic variants in CYP2D6, which give rise to genetic polymorphisms in 2D6-mediated metabolism, can be rationalized in terms of their position within the active site region. 4. The results of site-directed mutagenesis experiments are consistent with the CYP2D6 model generated from the CYP102 crystal structure. 5. The possibility of an alternative orientation within the active site may explain the CYP2D6-mediated metabolism of relatively large-sized substrates.
- 1 January 1997
- Published by Taylor & Francis in Xenobiotica
- Vol. 27 (4) , 319-340
Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102 : structural studies on specific CYP2D6substrate metabolism
1. A molecular model of CYP2D6 has been constructed from the bacterial form CYP102 via a homology alignment between the CYP2D subfamily and CYP102 protein sequences. 2. A number of typical CYP2D6 substrates are shown to fit the putative active site of the enzyme, as can the specific inhibitor quinidine. 3. Some of the allelic variants in CYP2D6, which give rise to genetic polymorphisms in 2D6-mediated metabolism, can be rationalized in terms of their position within the active site region. 4. The results of site-directed mutagenesis experiments are consistent with the CYP2D6 model generated from the CYP102 crystal structure. 5. The possibility of an alternative orientation within the active site may explain the CYP2D6-mediated metabolism of relatively large-sized substrates.
- 1 January 1996
- Published by Taylor & Francis in Xenobiotica
- Vol. 26 (1) , 1067-1086
Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals
- 1 January 1996
- Published by Taylor & Francis in Xenobiotica
- Vol. 26 (1) , 1067-1086
Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals